---
title: "12 Health Care Stocks Moving In Tuesday's Pre-Market Session"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294063861.md"
description: "In Tuesday's pre-market session, several healthcare stocks saw significant movement. Gossamer Bio surged 47.2% to $0.29, while Prelude Therapeutics rose 20.3%. Other gainers included ProMIS Neurosciences, Aldeyra Therapeutics, Altimmune, and IQVIA Holdings, with the latter rising on Q2 earnings news. Conversely, Replimune Group dropped 24.7%, followed by declines in Nexalin Technology, BiomX, Outlook Therapeutics, Autonomix Medical, and China SXT Pharmaceuticals."
datetime: "2026-07-28T12:05:58.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294063861.md)
  - [en](https://longbridge.com/en/news/294063861.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294063861.md)
---

# 12 Health Care Stocks Moving In Tuesday's Pre-Market Session

### Gainers

-   **Gossamer Bio** (NASDAQ:GOSS) shares moved upwards by 47.2% to $0.29 during Tuesday's pre-market session. The company's market cap stands at $97.4 million.
-   **Prelude Therapeutics** (NASDAQ:PRLD) shares moved upwards by 20.3% to $4.68. The market value of their outstanding shares is at $309.8 million.
-   **ProMIS Neurosciences** (NASDAQ:PMN) stock increased by 16.46% to $13.65. The company's market cap stands at $105.1 million.
-   **Aldeyra Therapeutics** (NASDAQ:ALDX) shares moved upwards by 11.04% to $1.76. The company's market cap stands at $95.6 million.
-   **Altimmune** (NASDAQ:ALT) stock rose 8.8% to $3.22. The market value of their outstanding shares is at $575.6 million.
-   **IQVIA Holdings** (NYSE:IQV) shares rose 8.76% to $231.9. The company's market cap stands at $35.5 billion. As per the news, the Q2 earnings report came out today.

### Losers

-   **Replimune Group** (NASDAQ:REPL) shares fell 24.7% to $6.5 during Tuesday's pre-market session. The company's market cap stands at $724.4 million.
-   **Nexalin Technology** (NASDAQ:NXL) stock decreased by 16.29% to $0.37. The market value of their outstanding shares is at $9.7 million.
-   **BiomX** (AMEX:PHGE) shares decreased by 12.92% to $0.17. The market value of their outstanding shares is at $2.1 million.
-   **Outlook Therapeutics** (NASDAQ:OTLK) shares decreased by 11.92% to $0.94. The company's market cap stands at $158.2 million.
-   **Autonomix Medical** (NASDAQ:AMIX) shares fell 11.83% to $2.46. The company's market cap stands at $1.5 million.
-   **China SXT Pharmaceuticals** (NASDAQ:SXTC) shares decreased by 11.61% to $0.06. The company's market cap stands at $2.6 million. **See Also:** www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

### Related Stocks

- [ALT.US](https://longbridge.com/en/quote/ALT.US.md)
- [OTLK.US](https://longbridge.com/en/quote/OTLK.US.md)
- [REPL.US](https://longbridge.com/en/quote/REPL.US.md)
- [SXTC.US](https://longbridge.com/en/quote/SXTC.US.md)
- [PHGE.US](https://longbridge.com/en/quote/PHGE.US.md)
- [ALDX.US](https://longbridge.com/en/quote/ALDX.US.md)
- [PRLD.US](https://longbridge.com/en/quote/PRLD.US.md)
- [GOSS.US](https://longbridge.com/en/quote/GOSS.US.md)
- [AMIX.US](https://longbridge.com/en/quote/AMIX.US.md)
- [IQV.US](https://longbridge.com/en/quote/IQV.US.md)
- [NXL.US](https://longbridge.com/en/quote/NXL.US.md)
- [PMN.US](https://longbridge.com/en/quote/PMN.US.md)
- [NXLIW.US](https://longbridge.com/en/quote/NXLIW.US.md)

## Related News & Research

- [Major Insider Move Signals Growing Confidence in Outlook Therapeutics](https://longbridge.com/en/news/294298016.md)
- [BiomX Amends Promissory Note, Issues Restricted Shares](https://longbridge.com/en/news/294079772.md)
- [IQVIA Holdings Inc. $IQV Shares Sold by California State Teachers Retirement System](https://longbridge.com/en/news/294474848.md)
- [BUZZ-IQVIA rises after raising annual profit forecast](https://longbridge.com/en/news/294057401.md)
- [Cetera Investment Advisers Acquires 7,517 Shares of IQVIA Holdings Inc. $IQV](https://longbridge.com/en/news/294025058.md)